You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 1, January 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Schizophrenia
 •Alert me on articles by topic

Elevated Prenatal Homocysteine Levels as a Risk Factor for Schizophrenia

Alan S. Brown, MD; Teodoro Bottiglieri, PhD; Catherine A. Schaefer, PhD; Charles P. Quesenberry Jr, PhD; Liyan Liu, MD, MSc; Michaeline Bresnahan, PhD; Ezra S. Susser, MD, DrPH

Arch Gen Psychiatry. 2007;64(1):31-39.

Context  Elevated prenatal homocysteine level is a plausible risk factor for schizophrenia because of its partial antagonism of N-methyl-D-aspartate receptors under physiologic glycine concentrations and its association with abnormal placental function and pregnancy complications.

Objective  We examined whether elevated maternal levels of homocysteine during the third trimester were associated with adult schizophrenia risk.

Design  Nested case-control study of a large birth cohort, born from 1959 through 1967 and followed up for schizophrenia from 1981 through 1997.

Setting  Population-based birth cohort and health plan.

Participants  Cases (n = 63) were diagnosed with schizophrenia and other spectrum disorders (mostly schizophrenia and schizoaffective disorder). Controls (n = 122) belonged to the birth cohort; had not been diagnosed with a schizophrenia spectrum or major affective disorder; and were matched to cases on date of birth, sex, length of time in the cohort, and availability of maternal serum samples.

Main Measures  Archived maternal serum samples were assayed for homocysteine levels during pregnancies of cases and matched controls.

Results  In a model that tested for a threshold effect of third-trimester homocysteine levels, an elevated homocysteine level was associated with a greater than 2-fold statistically significant increase in schizophrenia risk (odds ratio, 2.39; 95% confidence interval, 1.18-4.81; P = .02).

Conclusions  These findings indicate that elevated third-trimester homocysteine levels may be a risk factor for schizophrenia. Elevated third-trimester homocysteine levels may elevate schizophrenia risk through developmental effects on brain structure and function and/or through subtle damage to the placental vasculature that compromises oxygen delivery to the fetus. If future studies both replicate this association and support a causal link, then the use of folic acid supplementation would merit evaluation as a strategy for prevention of schizophrenia in offspring.


Author Affiliations: College of Physicians and Surgeons of Columbia University and New York State Psychiatric Institute (Drs Brown and Susser), and Mailman School of Public Health of Columbia University (Drs Brown, Bresnahan, and Susser), New York, NY; Baylor University Medical Center, Baylor Institute of Metabolic Disease, Dallas, Tex (Dr Bottiglieri); and Kaiser Permanente Division of Research, Oakland, Calif (Drs Schaefer, Quesenberry, and Liu).


RELATED LETTER

Elevated Prenatal Homocysteine Levels and the Risk of Schizophrenia
Stefan Bleich, Helge Frieling, and Thomas Hillemacher
Arch Gen Psychiatry. 2007;64(8):980-981.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Elevated Prenatal Homocysteine Levels and the Risk of Schizophrenia
Bleich et al.
Arch Gen Psychiatry 2007;64:980-981.
FULL TEXT  

The Homocysteine Hypothesis of Depression
Folstein et al.
Am. J. Psychiatry 2007;164:861-867.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.